261 related articles for article (PubMed ID: 24142271)
1. Inhibitory effect of doxycycline against dengue virus replication in vitro.
Rothan HA; Mohamed Z; Paydar M; Rahman NA; Yusof R
Arch Virol; 2014 Apr; 159(4):711-8. PubMed ID: 24142271
[TBL] [Abstract][Full Text] [Related]
2. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
3. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
4. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
[TBL] [Abstract][Full Text] [Related]
5. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
6. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.
Rothan HA; Mohamed Z; Suhaeb AM; Rahman NA; Yusof R
OMICS; 2013 Nov; 17(11):560-7. PubMed ID: 24044366
[TBL] [Abstract][Full Text] [Related]
7. Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus.
Rothan HA; Bahrani H; Rahman NA; Yusof R
BMC Microbiol; 2014 May; 14():140. PubMed ID: 24885331
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
9. Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro.
Flores-Ocelotl MR; Rosas-Murrieta NH; Moreno DA; Vallejo-Ruiz V; Reyes-Leyva J; Domínguez F; Santos-López G
BMC Complement Altern Med; 2018 Mar; 18(1):95. PubMed ID: 29548293
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
[TBL] [Abstract][Full Text] [Related]
12. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
[TBL] [Abstract][Full Text] [Related]
13. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
16. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
[TBL] [Abstract][Full Text] [Related]
18. Novel antiviral activity of bromocriptine against dengue virus replication.
Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
[TBL] [Abstract][Full Text] [Related]
19. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
20. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay.
Rothan HA; Zulqarnain M; Ammar YA; Tan EC; Rahman NA; Yusof R
Trop Biomed; 2014 Jun; 31(2):286-96. PubMed ID: 25134897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]